# The Effect of MK0633 in Patients With Chronic Asthma (0633-007)

> **NCT00404313** · PHASE2 · TERMINATED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 688 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** MK0633
- **DRUG:** Comparator: placebo

## Key facts

- **NCT ID:** NCT00404313
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-01
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 688 (ACTUAL)
- **Last updated:** 2015-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00404313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00404313, "The Effect of MK0633 in Patients With Chronic Asthma (0633-007)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00404313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*